Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avandia in colonic gene regulation (GReaT)
NCT00567593Phase 4Completed
- Sponsor
- James Lewis Recruitment
- Start
- Oct 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in inflammatory bowel disease (IBD), sponsored by James Lewis Recruitment. Started Oct 2007; status: completed.
02
Drugs
rosiglitazone
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT00567593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567593.